Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
VINO - Gaucho Group Holdings Inc - Stock Price Chart
TickerVINO [NASD]
CompanyGaucho Group Holdings Inc
CountryUSA
IndustryReal Estate - Diversified
Market Cap16.38MEPS (ttm)-30.32
P/E-EPS this Y59.26%
Forward P/E0.06EPS next Y-
PEG-EPS past 5Y18.46%
P/S8.31EPS next 5Y-
P/B1.80EPS Q/Q83.35%
Dividend-Sales Q/Q75.40%
Insider Own10.44%Inst Own0.04%
Insider Trans0.00%Inst Trans-
Short Float0.06%Earnings-
Analyst Recom1.00Target Price1375.20
Avg Volume65.77K52W Range1.56 - 57.90
Today 08:30AM Gaucho Group Holdings, Inc. Announces New Initiatives To Increase Stockholder Value (ACCESSWIRE) +16.93%
Sep-27-23 11:20AM Gaucho Group Holdings, Inc. Welcomes Amrita Bhalla to its Advisory Board (ACCESSWIRE)
Sep-22-23 12:00PM Gaucho Group Holdings, Inc. Announces Reverse Stock Split (ACCESSWIRE)
Aug-17-23 08:45AM Gaucho - Buenos Aires Unveils Premiere Sterling Silver Jewelry Collection (ACCESSWIRE)
Jul-11-23 08:30AM Gaucho - Buenos Aires Unveils Captivating Journey of Luxury and Adventure with Debut of Exquisite Travel Collection for Miami Swim Week (ACCESSWIRE)
May-09-23 09:00AM Gaucho Group Holdings, Inc. to Present at EF Hutton's Inaugural Global Conference (ACCESSWIRE) -6.97%
May-08-23 08:30AM Gaucho Group Holdings Projects Over $6 Million in Sales in 2023 Driven by Strong Demand for Luxury Real Estate Properties (ACCESSWIRE)
Feb-21-23 10:10AM Gaucho Group Holdings, Inc Announces Securement Of $5.6 Million Convertible Note (ACCESSWIRE) -5.62%
Feb-02-23 12:50PM Gaucho Group Holdings, Inc. Announces $44 Million ELOC (ACCESSWIRE) +339.02%
Jan-19-23 12:10PM Gaucho Group Holdings, Inc. Announces Growth Objectives for 2023 and Beyond (ACCESSWIRE) -8.60%
IKT - Inhibikase Therapeutics Inc - Stock Price Chart
TickerIKT [NASD]
CompanyInhibikase Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap5.51MEPS (ttm)-4.17
P/E-EPS this Y23.61%
Forward P/E-EPS next Y-3.94%
PEG-EPS past 5Y-76.13%
P/S22.04EPS next 5Y-
P/B0.28EPS Q/Q-0.18%
Dividend-Sales Q/Q1676.71%
Insider Own22.48%Inst Own18.52%
Insider Trans0.00%Inst Trans-23.13%
Short Float0.55%EarningsAug 14/a
Analyst Recom2.00Target Price27.00
Avg Volume48.05K52W Range0.95 - 6.94
Today 08:30AM Inhibikase Therapeutics Receives FDA Orphan Drug Designation for Risvodetinib for the Treatment of Multiple System Atrophy (GlobeNewswire) -26.43%
Sep-20-23 08:30AM Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity (GlobeNewswire) +17.82%
Aug-24-23 08:30AM Inhibikase Therapeutics Announces Development of Novel Formulation of risvodetinib (PR Newswire)
Aug-22-23 08:05AM Inhibikase Therapeutics to Present at the International Congress of Parkinson's Disease and Movement Disorders (PR Newswire) -10.33%
Aug-21-23 08:30AM Inhibikase Therapeutics Initiates Development of Second Generation c-Abl inhibitors and names IkT-148009 as risvodetinib (PR Newswire)
Aug-17-23 08:30AM Inhibikase Therapeutics Announces Completion of the 501 Bioequivalence Study of IkT-001Pro (PR Newswire)
Aug-15-23 11:47PM Q2 2023 Inhibikase Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -6.02%
Aug-14-23 04:20PM Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity (PR Newswire)
Aug-07-23 08:05AM Inhibikase Therapeutics to Report Second Quarter Financial Results on August 14, 2023 (PR Newswire)
Jul-17-23 04:05PM Inhibikase Therapeutics Regains Compliance with Nasdaq Listing Requirements (PR Newswire)
LVOX - LiveVox Holdings Inc - Stock Price Chart
TickerLVOX [NASD, RUT]
CompanyLiveVox Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap341.00MEPS (ttm)-0.29
P/E-EPS this Y92.78%
Forward P/E40.22EPS next Y-
PEG-EPS past 5Y-
P/S2.38EPS next 5Y-
P/B3.78EPS Q/Q60.15%
Dividend-Sales Q/Q7.24%
Insider Own86.84%Inst Own19.42%
Insider Trans0.00%Inst Trans-0.37%
Short Float8.10%EarningsAug 08/a
Analyst Recom1.00Target Price5.62
Avg Volume39.70K52W Range1.70 - 3.48
Today 07:34AM NICE to Acquire LiveVox, Revolutionizing How Organizations Manage Proactive Outreach With the Power of Conversational AI at Scale (Business Wire) +8.38%
Sep-27-23 09:00AM VanillaSoft Receives Significant Growth Investment from Tritium Partners (GlobeNewswire)
09:00AM Arrivia, the Worlds Largest Stand-Alone Travel Loyalty Provider, Partners with LiveVox to Optimize Traveler Customer Experience (Business Wire)
Sep-21-23 09:00AM LiveVox Awarded Exemplary Status in Ventana Researchs 2023 Buyers Guide for Contact Center Suites (Business Wire)
Aug-15-23 09:00AM LiveVox Partners With Jenne to Amplify its North American CCaaS Customer Base (Business Wire)
Aug-08-23 04:05PM LiveVox Announces Second Quarter 2023 Financial Results (Business Wire)
Jul-20-23 08:30AM LiveVox to Report Second Quarter 2023 Financial Results on August 8, 2023 (Business Wire)
Jun-08-23 08:30AM OTDAmericas Selects LiveVoxs Cloud Contact Center Platform to Optimize Customer Engagement and Mitigate Risk (Business Wire)
May-11-23 08:00AM LiveVox to Present at Upcoming Investor Conferences (Business Wire)
May-09-23 04:05PM LiveVox Announces First Quarter 2023 Financial Results (Business Wire)
VVOS - Vivos Therapeutics Inc - Stock Price Chart
TickerVVOS [NASD]
CompanyVivos Therapeutics Inc
CountryUSA
IndustryMedical Devices
Market Cap9.11MEPS (ttm)-0.77
P/E-EPS this Y55.29%
Forward P/E-EPS next Y66.67%
PEG-EPS past 5Y-18.87%
P/S0.59EPS next 5Y-
P/B4.33EPS Q/Q43.91%
Dividend-Sales Q/Q-18.86%
Insider Own16.80%Inst Own15.68%
Insider Trans0.78%Inst Trans-0.58%
Short Float2.12%EarningsAug 16/a
Analyst Recom1.00Target Price2.25
Avg Volume1.55M52W Range0.18 - 2.96
Today 07:30AM Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark Clear Aligners to Its National Network of Providers (GlobeNewswire) +64.59%
Oct-02-23 07:30AM New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference (GlobeNewswire)
Aug-23-23 09:55AM Here's Why Vivos Therapeutics, Inc. (VVOS) Could be Great Choice for a Bottom Fisher (Zacks)
Aug-16-23 04:05PM Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +5.12%
07:30AM Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Aug-14-23 05:06PM Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Aug-10-23 08:31PM Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call (GlobeNewswire) +9.97%
Jun-15-23 12:55PM Vivos Therapeutics highlights 1Q financial and operational growth with major acquisition (News Direct) +15.77%
Jun-13-23 08:50AM Looking for a Fast-paced Momentum Stock at a Bargain? Consider Vivos Therapeutics, Inc. (VVOS) (Zacks) +14.55%
Jun-10-23 04:31PM Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q1 2023 Earnings Call Transcript (Insider Monkey)
SNTI - Senti Biosciences Inc. - Stock Price Chart
TickerSNTI [NASD]
CompanySenti Biosciences Inc.
CountryUSA
IndustryBiotechnology
Market Cap17.73MEPS (ttm)-1.65
P/E-EPS this Y31.29%
Forward P/E-EPS next Y29.59%
PEG-EPS past 5Y-
P/S4.38EPS next 5Y-
P/B0.18EPS Q/Q50.84%
Dividend-Sales Q/Q-31.00%
Insider Own41.06%Inst Own17.01%
Insider Trans0.00%Inst Trans-4.32%
Short Float0.80%EarningsAug 11/b
Analyst Recom2.33Target Price4.00
Avg Volume79.84K52W Range0.33 - 8.77
Sep-27-23 09:05AM Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meeting (GlobeNewswire)
Sep-26-23 04:05PM Senti Bio to Participate in Upcoming Conferences (GlobeNewswire)
Sep-05-23 08:30AM Senti Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-11-23 09:50AM Senti Biosciences, Inc. (SNTI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
08:35AM Senti Bio Announces Second Quarter 2023 Results and Pipeline Updates (GlobeNewswire)
Aug-10-23 08:35AM Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon Partners (GlobeNewswire)
Jun-05-23 08:04AM Here's Why Senti Biosciences (NASDAQ:SNTI) Must Use Its Cash Wisely (Simply Wall St.)
May-20-23 08:05AM Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting (GlobeNewswire)
May-09-23 04:05PM Senti Bio Announces First Quarter 2023 Results and Pipeline Updates (GlobeNewswire)
May-02-23 04:45PM Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual Meeting (GlobeNewswire)
SONX - Sonendo Inc - Stock Price Chart
TickerSONX [NYSE]
CompanySonendo Inc
CountryUSA
IndustryMedical Devices
Market Cap16.32MEPS (ttm)-0.94
P/E-EPS this Y52.36%
Forward P/E-EPS next Y16.53%
PEG-EPS past 5Y-
P/S0.37EPS next 5Y-
P/B0.31EPS Q/Q66.99%
Dividend-Sales Q/Q4.70%
Insider Own23.47%Inst Own58.72%
Insider Trans-0.59%Inst Trans33.43%
Short Float0.68%EarningsAug 09/a
Analyst Recom1.50Target Price2.06
Avg Volume59.50K52W Range0.31 - 2.95
Today 08:00AM Sonendo Announces New Partnership Agreements with Two Leading Specialty DSOs to Expand Access to the GentleWave Procedure for Elevated Root Canal Treatment (Business Wire)
07:55AM Why Is Sonendo (SONX) Stock Up 38% Today? (InvestorPlace)
Oct-02-23 04:40PM Sonendo, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Trading Share Price Listing Rule (Business Wire)
Sep-28-23 08:00AM Sonendo Announces Launch of Second Generation CleanFlow Procedure Instrument for Heightened Efficacy and Ease of Use (Business Wire)
Sep-26-23 08:00AM Sonendo, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08 (Business Wire)
Sep-20-23 08:00AM Sonendo to Participate at the LD Micro Main Event XVI Conference (Business Wire)
Sep-18-23 08:00AM Sonendo to Participate at the Gilmartin Group Emerging Growth Company Showcase (Business Wire)
Sep-05-23 08:00AM Sonendo Hosts Second Women in Endodontics Summit (Business Wire)
Aug-10-23 07:42AM Q2 2023 Sonendo Inc Earnings Call (Thomson Reuters StreetEvents) -5.60%
Aug-09-23 05:30PM Sonendo, Inc. (SONX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
BCLI - Brainstorm Cell Therapeutics, Inc. - Stock Price Chart
TickerBCLI [NASD]
CompanyBrainstorm Cell Therapeutics, Inc.
CountryUSA
IndustryBiotechnology
Market Cap8.55MEPS (ttm)-0.60
P/E-EPS this Y18.18%
Forward P/E-EPS next Y14.81%
PEG-EPS past 5Y-20.66%
P/S-EPS next 5Y-
P/B-EPS Q/Q30.47%
Dividend-Sales Q/Q-
Insider Own19.34%Inst Own12.84%
Insider Trans0.13%Inst Trans-1.22%
Short Float9.68%EarningsAug 14/b
Analyst Recom1.00Target Price10.50
Avg Volume632.22K52W Range0.16 - 4.47
Oct-02-23 07:00AM BCLI: Advisory Panel Votes Against Recommending Approval of NurOwn® (Zacks)
Sep-27-23 10:48PM BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS (PR Newswire)
06:15PM FDA advisers vote against experimental ALS treatment pushed by patients (AP Finance)
07:00AM BrainStorm Cell Therapeutics Stock Trading Halted Today (PR Newswire)
Sep-26-23 12:17PM BCLI: Public Support for NurOwn® from Prominent ALS Specialists (Zacks) -8.35%
Sep-25-23 08:13AM FDA staff reviewers raise concerns over BrainStorm Cell's ALS therapy (Reuters) -47.57%
Aug-18-23 08:34AM BCLI: Preparing for AdCom on September 27, 2023 (Zacks)
Aug-15-23 03:11AM Q2 2023 Brainstorm Cell Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -6.59%
Aug-14-23 07:05AM BrainStorm Cell Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update (PR Newswire)
Aug-07-23 04:05PM BrainStorm to Announce Second Quarter 2023 Financial Results and Provide a Corporate Update (PR Newswire)
FFSG - FormulaFolios Smart Growth ETF - Stock Price Chart
TickerFFSG [AMEX]
CompanyFormulaFolios Smart Growth ETF
CountryUSA
IndustryExchange Traded Fund
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend1.71%Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume1.49K52W Range28.75 - 33.47
Oct-07-22 03:00PM Odds & Ends: BlackRock Adds Floating Rate ETF (ETF.com)
CDT - Conduit Pharmaceuticals Inc - Stock Price Chart
TickerCDT [NASD]
CompanyConduit Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap11.58MEPS (ttm)0.02
P/E178.28EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.44EPS Q/Q-708.82%
Dividend-Sales Q/Q-
Insider Own26.31%Inst Own53.76%
Insider Trans0.00%Inst Trans1.29%
Short Float0.17%Earnings-
Analyst Recom-Target Price-
Avg Volume78.98K52W Range4.44 - 25.00
Sep-22-23 09:01AM Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination (GlobeNewswire)
Sep-20-23 05:40PM Murphy Canyon Acquisition Corp. Announces Stockholder Approval of the Proposed Combination with Conduit Pharmaceuticals Limited (ACCESSWIRE) -8.94%
Sep-13-23 08:30AM Presidio Property Trust, Inc. Announces Establishment of a Special Committee of the Board and Exploration of Strategic Alternatives (GlobeNewswire)
Sep-07-23 04:30PM Murphy Canyon Acquisition Corp. Announces Postponement of Its Special Meeting of Stockholders for Approving Its Initial Business Combination With Conduit (ACCESSWIRE)
Aug-31-23 04:05PM Murphy Canyon Acquisition Corp. Announces Postponement of its Special Meeting of Stockholders for Approving its Initial Business Combination with Conduit (ACCESSWIRE)
Aug-16-23 08:30AM SEC Declares Form S-4 Registration Statement "Effective" for Proposed Business Combination of Murphy Canyon Acquisition Corp. with Conduit Pharmaceuticals Limited (ACCESSWIRE)
MDAI - Spectral AI Inc - Stock Price Chart
TickerMDAI [NASD]
CompanySpectral AI Inc
CountryUSA
IndustryMedical Devices
Market Cap21.42MEPS (ttm)-0.26
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own93.24%Inst Own4.31%
Insider Trans0.00%Inst Trans7.31%
Short Float7.17%Earnings-
Analyst Recom-Target Price-
Avg Volume178.33K52W Range2.20 - 19.50
Oct-02-23 08:00AM Spectral AI Adds Healthcare Services Leader and Population Health Expert Deepak Sadagopan to Board of Directors (GlobeNewswire)
Sep-29-23 01:17PM Spectral AI announces "single largest contract to date" (News Direct) -18.00%
Sep-28-23 10:01AM Spectral MD Awarded BARDA Project BioShield Contract Valued at $149 Million for AI-Driven DeepView Burn Wound Imaging Technology (GlobeNewswire) -10.57%
Sep-20-23 04:15PM Spectral AI to Present at 2023 Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Aug-14-23 07:00AM Spectral MD Holdings, Ltd. (Spectral MD or the Company) ISO 13485 Certification Received for AI-Driven DeepView® Wound Imaging System (GlobeNewswire)
Jun-20-23 07:00AM Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Completion of ISO 13485 Certification Audit (Business Wire)
Jun-13-23 07:00AM Spectral MD Holdings, Ltd ("Spectral MD" or the "Company") Announces Publication of Peer Reviewed Proof-of-Concept Study Evaluating DeepView® Technology in Journal of Burn Care & Research (Business Wire)
May-18-23 07:00AM Spectral MD Announces Podium Presentation at 2023 American Burn Association Annual Conference (Business Wire)
May-09-23 11:45AM Wensheng Fan, CEO of Spectral MD, Discusses How Artificial Intelligence (AI) Can Revolutionize the Standard of Care in Burn Wound Diagnostics (Business Wire)
Apr-18-23 04:55PM Spectral MD Holdings, Ltd. $4.0 Million Grant Award from the Medical Technology Enterprise Consortium (Business Wire)
123456⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2023 FINVIZ.com. All Rights Reserved.